CytoReason

Bring your data to life

Tel Aviv, Israel · Founded 2016 · $100.0M raised

Headquarters
Tel Aviv
Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$100.0M
Last Round
$80.0M Series BJul 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

CytoReason builds computational disease models that digest and organize vast volumes of human molecular data, identifying which genes are active in which cells, pathways, diseases, and drugs. Founded in 2016 to close the gap between exploding data volumes and human analytic capacity, its platform is used by five of the world's top ten pharma companies to prioritize drug targets, find biomarkers, and shorten trial phases.

Summary

CytoReason is an Artificial Intelligence company based in Tel Aviv, Israel, founded in 2016. It has raised $100.0M in total across 3 rounds, most recently a $80.0M Series B round in Jul 2024. Investors include Pfizer Ventures, Nvidia and Thermo Fisher Scientific.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJul 2024
$80.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

CytoReason on Indexed.vc
<a href="https://indexed.vc/companies/cytoreason"><img src="https://indexed.vc/api/badge/company/cytoreason" alt="CytoReason on Indexed.vc" width="260" height="76" /></a>